About this trial
To compare the efficacy and safety of flexible ureterorenoscopy (fURS) versus extracorporeal shock wave lithotripsy (ESWL) in managing lower calyceal renal stones ≤15 mm and \<1000 HU.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Adults (≥18 y)
Lower-calyx stone
Less than or equal15 mm
Mean Hounsfield (HU) <1000
Disqualifiers
Pregnancy
Uncorrected coagulopathy
Active UTI/obstruction
Anatomical barriers to Flexible Ureteroscopy or extracorporeal shock wave lithotripsy coupling (e.g., prohibitive SSD/BMI).
Trial design
Parallel
Treatments tested in this trial
Flexible Ureteroscopy
Procedure/SurgeryFlexible Ureterorenoscopy
extracorporeal shock wave lithotripsy (ESWL)
Procedure/Surgeryextracorporeal shock wave lithotripsy (ESWL)
Treatment groups
Trial outcomes
Primary outcomes
Stone-free rate at 1 months on low-dose NCCT (no fragment >2 mm; report CIRF separately)
Stone-free rate at 1 months on low-dose NCCT (no fragment \>2 mm; report CIRF separately)
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: